Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents: A new generation of therapeutics

被引：32

作者：

Hursey, M ^{[1
]}

Newton, DL ^{[1
]}

Hansen, HJ ^{[1
]}

Ruby, D ^{[1
]}

Goldenberg, DM ^{[1
]}

Rybak, SM ^{[1
]}

机构：

[1] NCI, Div Canc Treatment & Diag, Dev Therapeut Program, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA

来源：

LEUKEMIA & LYMPHOMA | 2002年 / 43卷 / 05期

关键词：

antibody; ribonuclease; cancer; immunotoxin; apoptosis; CD22;

D O I：

10.1080/10428190290021380

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Targeting CD22 on human B-cells with a monoclonal antibody conjugated to a cytotoxic RNAse causes potent and specific killing of the lymphoma cells in vitro. This translates to anti-tumor effects in human lymphoma models in SCID mice. RNA damage caused by RNAses could be an important alternative to standard DNA-damaging chemotherapeutics. A second generation construct with an improved recombinant cytotoxic RNAse is described. Targeted RNAses may overcome problems of toxicity and immunogenicity associated with plant or bacterial toxin-containing immunoconjugates.

引用

页码：953 / 959

页数：7

共 49 条

[1] FULL ANTITUMOR ACTION OF RECOMBINANT SEMINAL RIBONUCLEASE DEPENDS ON THE REMOVAL OF ITS N-TERMINAL METHIONINE [J].

ADINOLFI, BS ;

CAFARO, V ;

DALESSIO, G ;

DIDONATO, A .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 213 (02) :525-532

[2]

ALEKSANDROWICZ J, 1958, LANCET, V2, P420

[3]

ARDELT W, 1991, J BIOL CHEM, V266, P245

[4]

Benhattar J, 1996, INT J CANCER, V69, P190, DOI 10.1002/(SICI)1097-0215(19960621)69:3<190::AID-IJC7>3.0.CO

[5]

2-V

[6] Role of the N terminus in RNase a homologues: Differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity [J].

Boix, E ;

Wu, YN ;

Vasandani, VM ;

Saxena, SK ;

Ardelt, W ;

Ladner, J ;

Youle, RJ .

JOURNAL OF MOLECULAR BIOLOGY, 1996, 257 (05) :992-1007

[7] Evaluation of immunotoxins containing single-chain ribosome-inactivating proteins and an anti-CD22 monoclonal antibody (OM124):: in vitro and in vivo studies [J].

Bolognesi, A ;

Tazzari, PL ;

Olivieri, F ;

Polito, L ;

Lemoli, R ;

Terenzi, A ;

Pasqualucci, L ;

Falini, B ;

Stirpe, F .

BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 (01) :179-188

[8]

CASELLAS P, 1988, IMMUNOTOXINS, P351

[9] A gender-specific mRNA encoding a cytotoxic ribonuclease contains a 3′ UTR of unusual length and structure [J].

Chen, SL ;

Le, SY ;

Newton, DL ;

Maizel, JV ;

Rybak, SM .

NUCLEIC ACIDS RESEARCH, 2000, 28 (12) :2375-2382

[10] CYTOSTATIC AND CYTO-TOXIC EFFECTS OF PANNON (P-30 PROTEIN), A NOVEL ANTICANCER AGENT [J].

DARZYNKIEWICZ, Z ;

CARTER, SP ;

MIKULSKI, SM ;

ARDELT, WJ ;

SHOGEN, K .

CELL AND TISSUE KINETICS, 1988, 21 (03) :169-182

← 1 2 3 4 5 →